SCN2A and SCN8A developmental and epileptic encephalopathies | Clinical Trials Search

387,376 results for “SCN2A and SCN8A developmental and epileptic encephalopathies”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Study to Evaluate NBI-921352 as Adjunctive Therapy in Subjects With SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE)

8 participants · First posted May 5, 2021

Not yet recruiting

Developmental and Epileptic Encephalopathies Diagnosed Via Long-read Genome Sequencing

20 participants · First posted Feb 9, 2026

Active, not recruiting

A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)

77 participants · First posted Apr 19, 2023

Natural History Study of Infants and Children With Developmental and Epileptic Encephalopathies

58 participants · First posted Sep 3, 2020

Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies

52 participants · First posted May 6, 2022

Study of TAK-935 as an Adjunctive Therapy in Participants With Developmental and/or Epileptic Encephalopathies

18 participants · First posted May 25, 2017

A Prospective, Remote Observational Study in Pediatric Participants With Early-Onset SCN2A-Developmental and Epileptic Encephalopathy

5 participants · First posted Jun 7, 2022

Extension Study to Evaluate How Safe and Tolerable NBI-921352 is as an Adjunctive Therapy for Participants With SCN8A-DEE

8 participants · First posted Feb 7, 2022

Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes

20 participants · First posted Feb 10, 2022

Home Ultra-long Term EEG Monitoring for Rare Epilepsies and Developmental and Epileptic Encephalopathies

30 participants · First posted Mar 4, 2025

Page 1 of 33988